Both the knockout or the knockdown of SNRPA via CRISPR/Cas9 and shRNA techniques can reverse the resistance of cisplatin‐resistant lung adenocarcinoma (LUAD) cells to cisplatin. The gene discussed is SNRPA; the disease is lung adenocarcinoma.